Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-09

Clinical Trial Update: The Effect of Mouthrinses Containing Bamboo Salt, Magnolia Bark and Centella Asiatica on Reducing Plaque and Gingivitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a mouthwash containing bamboo salt, Magnolia bark, and Centella asiatica for reducing plaque and gingivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mouthrinse containing bamboo salt, Magnolia bark and Centella asiatica

Snippet

Sponsor: Seoul National University | Conditions: Gingivitis, Dental Plaque | Phase 3 | Status: COMPLETED